Lv52
970 积分 2023-07-20 加入
CLO25-067: Risk of Trastuzumab Deruxtecan (T-DXd) Associated Interstitial Lung Disease (ILD)/Pneumonitis: A Real-World Population-Based Propensity-Matched Analysis
24天前
已完结
Pneumopathies interstitielles diffuses induites par les anticorps conjugués
24天前
已关闭
Mining and analysis of adverse event signals of trastuzumab deruxtecan via real-world data of FDA adverse event reporting system database from 2019 to 2023
24天前
已完结
Incidence of antibody–drug conjugates-related pneumonitis in patients with solid tumors: A systematic review and meta-analysis
24天前
已完结
Adverse effect of trastuzumab deruxtecan in solid tumours: a systematic review and meta-analysis
24天前
已完结
Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management
24天前
已完结
The safety of trastuzumab deruxtecan (DS‐8201) with a focus on interstitial lung disease and/or pneumonitis: A systematic review and single‐arm meta‐analysis
24天前
已完结
Study on the common mechanisms of gastroesophageal reflux disease and interstitial lung disease
24天前
已关闭
Time trends in the incidence of interstitial lung disease across Brazil, Russia, India, China and South Africa (BRICS) from 1990 to 2019: An age‐period‐cohort analysis
24天前
已完结
Inhalational exposures associated with risk of interstitial lung disease: a systematic review and meta-analysis
24天前
已完结
皖公网安备34019202002308
